PHIBRO ANIMAL HEALTH CORP (PAHC) Stock Price, Financials & Summary

Price chart

Sep 21Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20

Key dataOct 20, 2026

Open$39.00

From 52W high−33.73%

Volume34412.00

Market cap$1.60B

P/E (TTM)16.1x

P/S (TTM)1.1x

Div yield1.22%

Key dataOct 20, 2026

Open

$39.00

From 52W high

−33.73%

Volume

34412.00

Market cap

$1.60B

ValuationView details →

P/E (Fwd)

11.2x

EV/EBITDA

9.8x

P/E (TTM)

16.1x

RSI (14)

66.0

MomentumView details →

1D Return

+0.36%

YTD Return

+5.91%

SummaryUpdated Jun 1, 2026

Phibro Animal Health Corporation (NASDAQ:PAHC) is a specialty animal health company that develops, manufactures, and markets products for livestock and companion animals. Founded as Philipp Brothers Chemicals in the early 20th century, the company changed its name to Phibro Animal Health Corporation in 2003 and went public in 2014. Headquartered in Teaneck, New Jersey, Phibro operates globally with manufacturing facilities in the United States, Brazil, and Ireland, serving customers across North America, Latin America, Europe, Asia Pacific, and other international markets.

Ask drillr about PHIBRO ANIMAL HEALTH CORP →

ValuationView details →

P/E (Fwd)

11.2x

P/E (TTM)

16.1x

EV/EBITDA

9.8x

EV/Sales

1.5x

P/S (TTM)

1.1x

P/B (TTM)

4.2x

ProfitabilityView details →

Gross Margin

33.71%

Net Margin

6.57%

EBITDA Margin

15.58%

ROE (TTM)

25.87%

ROA (TTM)

6.64%

Asset Turnover

1.03x

GrowthView details →

Revenue YoY

+17.12%

EPS YoY

+106.72%

FCF YoY

−76.41%

Revenue CAGR 3Y

+15.79%

EPS CAGR 3Y

+44.82%

EBITDA YoY

+59.27%

MomentumView details →

1D Return

+0.36%

YTD Return

+5.91%

1Y Return

−2.59%

RSI (14)

66.0

vs 50D SMA

+9.27%

vs 200D SMA

−4.16%

Capital & dividendView details →

Debt/Equity

2.05x

Current Ratio

2.96x

Quick Ratio

1.27x

Div Yield

1.22%

Div Rate

$0.48

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

$0.85

EPS Surprise

18.72%

Beats (12Q)

10/12

Next Q EPS Est

$0.94

Avg Surprise (4Q)

18.52%

Rev Surprise

2.78%

Financials snapshotView financials →

Revenue (TTM)

1.52B

Net Income (TTM)

99.72M

Op. CF (TTM)

68.95M

Next earningsNov 4, 2026 →

Latest newsMore news →

Phibro Animal Health Corporation's board declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock, payable on September 23, 2026, to stockholders of record on September 2, 2026.84d ago

Similar companies

ANI Pharmaceuticals, Inc.ANIP CF PharmTech, Inc.02652.HK ST金花600080.SH Pacira BioSciences, Inc.PCRX Dawnrays Pharmaceutical (Holdings) Limited02348.HK Golden Throat Holdings Group Company Limited06896.HK Find similar companies →

Latest newsMore news →

Phibro Animal Health Corporation reported financial results for the fourth quarter and fiscal year ended June 30, 2026, with net sales of $396.7 million and net income of $21.7 million for the quarter, and provided financial guidance for fiscal year 2027.55d ago Phibro Animal Health Corporation's board declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock, payable on September 23, 2026, to stockholders of record on September 2, 2026.84d ago